St. Charles is One of Nine Hospitals Nationwide and Only on LI To Examine Indego Exoskeleton for Improved Walking in Paralyzed Patients
St. Charles is one of nine hospitals in the U.S. and the only hospital on Long Island to conduct a clinical trial of the Indego exoskeleton, an FDA-approved, wearable robotic frame that enables individuals with lower-body paralysis to walk. Researchers will assess Indego as a tool to help improve walking in patients with a spinal cord injury.
“Technology is the future of rehabilitation for individuals with neurologic disorders, such as spinal cord injury,” said Jennifer Semel, MD, medical director, Physical Medicine and Rehabilitation, St. Charles. “In investigating the impact of this exoskeleton for rehabilitation, St. Charles aims to help advance technology in the field.”
Indego is the second lower-limb exoskeleton used for rehabilitation to receive FDA-approval. The FDA granted clearance for the device in March 2016 following a large scale clinical trial testing its safety.